Research Interests
Our key areas of research include:
1. mRNA Technology and Therapeutics for CVD: Designing, developing, delivering, and applying modified mRNA (modRNA) technology or mRNA therapeutics for cardiovascular conditions.
2. Mechanisms of Cardiovascular Function, Pathology and Regeneration: Investigating the molecular and cellular mechanisms underlying cardiovascular development, metabolism, diseases, and regeneration.
3. Cell-Specific mRNA Therapeutics: Creating platforms for cell-specific mRNA expression and delivery aimed at treating cardiovascular diseases.
4. mRNA Delivery Systems: Developing lipid nanoparticle (LNP) and non-LNP-based delivery platforms for the targeted delivery of mRNA in CVD and cardiovascular therapies.
Clinical Interests
Our lab is currently focused on discovering novel targets, molecular pathways, and leveraging mRNA and cell-specific mRNA as innovative therapeutic modalities for targeting cardiovascular diseases (CVD).
Education, Training & Credentials
- Associate Scientist – Center for Translational Medicine, Lewis Katz School of Medicine at Temple University
- Post-doctoral Fellow – Icahn School of Medicine at Mount Sinai Hospital, New York
- Post-doctoral Fellow – Ohio State University
- PhD – Cardiovascular Regeneration, Max Planck Institute for Heart and Lung Research, and Justus Liebig University Giessen, Germany
- M.Sc. – Dr. B. A. M. University, India
Memberships
- American Heart Association (AHA)
- South Asian Heart Association (SAHA)
Honors & Awards
- Melvin L. Marcus Early Career Investigator Award in Basic Cardiovascular Sciences Award (BCVS< AHA) – Finalist, 2022
- International Society for Heart Research- North American Society (ISHR-NAS) Young Investigator Competitions Award (YICA), ISHR-NAS-(Runner up), 2022
- ISHR-NAS 2021 Conference Travel Grant, 2021
- Outstanding Research Innovation award at Mount Sinai, New York, 2017
- Gold Winner of Student Sponsorship by Primer Design, 2013
- PROMISE PhD Fellowship (Germany-Spain), 2014